Spravato for depression is a fast acting clinic based option for adults with TRD or MDD in Atlanta. Learn how it works who qualifies and what to expect
Table of Contents
If you live with depression that will not lift you are not alone. Many adults try more than one antidepressant and still feel stuck. Spravato for depression is a fast acting option that is delivered in a clinic under close monitoring. It is approved by the Food and Drug Administration for adults with Treatment Resistant Depression also called TRD. It is also approved for adults with Major Depressive Disorder also called MDD who have acute suicidal thoughts or behavior.
Who Spravato may help
Spravato is considered when at least two antidepressants have not provided relief at the right dose and time. In TRD an adult can receive Spravato by itself or together with an oral antidepressant. In MDD with acute suicidal thoughts or actions Spravato is given with an oral antidepressant. The goal is to relieve symptoms quickly while a longer plan takes shape. These indications come from the current FDA label.
Adults in Atlanta often ask if they are candidates. A careful intake checks past medications medical history and current symptoms. Your Atlanta Spravato and TMS Center team guides this step and answers questions before day one.
How Spravato works
Most antidepressants act on serotonin or norepinephrine. Spravato works on the NMDA receptor which is part of the glutamate system. This different path can help reset communication between brain cells. Research supported by the National Institute of Mental Health shows that esketamine the active medicine in Spravato can reduce symptoms rapidly in some people with TRD.
Safety guardrails you can count on
Spravato is used only in certified clinics through a program called a Risk Evaluation and Mitigation Strategy also called REMS. This is a safety system that manages known risks such as sedation dissociation changes in breathing blood pressure increases and the potential for abuse or misuse. You self administer the nasal spray under direct supervision then you remain on site for at least two hours while a clinician monitors you until you are medically stable. The medicine is never dispensed for home use. The FDA requires this process and it is the same at every certified site including our Atlanta clinic.
The FDA label also advises you not to drive or operate machinery until the next day after a full night of sleep. Plan to have a trusted person drive you home after each session.
What to expect at Atlanta Spravato and TMS Center
Before your session
You will review your full medical history with the care team. Follow simple fasting guidelines which commonly include no food for two hours and no liquids for thirty minutes before treatment. If you use other nasal sprays use them at least one hour before your visit unless your clinician says otherwise. Arrange a ride home. The team will confirm benefits and help with program enrollment so you can focus on care.
During your session
You will take Spravato as a nasal spray under direct supervision in a quiet room. A clinician checks your blood pressure and other vital signs and stays with you as needed. Common side effects during treatment can include dizziness nausea a feeling of calm or dreamlike detachment and sleepiness. Most effects fade the same day. You will rest while the team watches for comfort and safety.
After your session
You remain in the clinic for at least two hours. You leave only after a clinician confirms you are stable. Avoid driving working with machinery or making major decisions until the following day after a full night of sleep. Plan a light schedule after each visit.
Your treatment schedule
Spravato follows a structured schedule that most adults find easy to remember. Weeks one through four are two sessions each week. Weeks five through eight are one session each week. Week nine and beyond is weekly or every two weeks based on your response at the lowest frequency that maintains your progress. Doses are 56 milligrams or 84 milligrams and are set with your clinician. This schedule comes from the FDA label.
How fast results may appear
A key reason many people choose Spravato for depression is speed. In pivotal trials for TRD the effect of Spravato added to standard care was seen as early as about twenty four hours and continued through the first four weeks. Many people report relief within the first few doses though responses vary and ongoing care is important.
How Spravato differs from ketamine at home
You may have heard about mail order or at home ketamine. The FDA has warned that compounded ketamine products are not approved for any psychiatric condition and are not part of the REMS safety program. Spravato is different. It is FDA approved for TRD and for depressive symptoms in MDD with acute suicidal thoughts or behavior and must be given in a certified clinic with monitoring. If you are weighing options ask about these differences so you can choose a regulated and supervised path.
Who should not receive Spravato
Spravato is not approved for children. Your team will check for specific medical conditions and medicines that may raise risk. The label includes warnings about blood pressure increases sedation dissociation and breathing problems and advises careful use in people with a history of substance use. Your clinician will review benefits and risks and create a plan that fits your health history.
Depression is common and treatable
Depression affects millions of adults in the United States. Recent federal data show that symptoms of depression are common across age groups and have increased in the last decade. If you have struggled with daily pills and do not feel better you still have options. Rapid acting care in a monitored setting may help you get traction while you continue therapy support and long term planning.
How Atlanta Spravato and TMS Center supports you
Our clinic provides structured preparation in clinic administration and post treatment monitoring so you feel supported at every step. We also help with benefits checks and enrollment support programs so eligible patients can access savings and care coordination. If you are not a candidate for Spravato we can discuss other advanced options such as TMS Therapy which does not use medicine and is also delivered in our clinic.
Take the next step in Atlanta
If you are exploring Spravato for depression in Atlanta our team is ready to help you decide with confidence. We will review your history confirm eligibility and answer every question. Request a Spravato evaluation and we will plan your first visit together.
Helpful sources to explore:
- FDA Access Data
- Depression Prevalence in Adolescents and Adults: United States, August 2021–August 2023
- Spravato (Esketamine). CIII Nasal Spray
- Spravato: What to Expect
- FDA warns patients and health care providers about potential risks associated with compounded ketamine products, including oral formulations, for the treatment of psychiatric disorders
- Cracking the Ketamine Code
